Debiopharm inks deal with INC Research
This article was originally published in Scrip
Executive Summary
The CRO INC Research has formed a strategic partnership with Swiss biopharmaceutical company Debiopharm, which will see the CRO manage a clinical study for Debio 0932, while both have agreed a framework for INC's collaboration on future trials.